Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Magid

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Academy of Dermatology|October 13, 2012
Patients labeled with delusions of parasitosis compose a heterogenous group: a retrospective study from a referral centerJason S Reichenberg, Michelle Magid, Christine A Jesser, et al.
Toxins|June 23, 2022
Treatment of Depression with Botulinum ToxinMarc Axel Wollmer, Michelle Magid, Tillmann H C Kruger, et al.
Journal of Psychiatric Practice|November 19, 2014
Emergency ECT in an incapacitated, medically compromised patient with Huntington's diseaseMichelle Magid, Kenneth Trevino, William H Reid, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 19, 2018
Isotretinoin: the ups are just as troubling as the downsJay M Truitt, Jason S Reichenberg, Kevin G Sharghi, et al.
Journal of Psychiatric Research|February 12, 2021
Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysisJara Schulze, Insa Neumann, Michelle Magid, et al.
Journal of the American Academy of Dermatology|December 26, 2015
Botulinum toxin for depression: Does patient appearance matter?Jason S Reichenberg, Aaron J Hauptman, Henry T Robertson, et al.
The Journal of Clinical Psychiatry|June 10, 2014
Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled studyMichelle Magid, Jason S Reichenberg, Poppy E Poth, et al.
Frontiers in Psychiatry|April 19, 2014
Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trialM Axel Wollmer, Nadeem Kalak, Stefanie Jung, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Academy of Dermatology|October 13, 2012
Patients labeled with delusions of parasitosis compose a heterogenous group: a retrospective study from a referral centerJason S Reichenberg, Michelle Magid, Christine A Jesser, et al.
Toxins|June 23, 2022
Treatment of Depression with Botulinum ToxinMarc Axel Wollmer, Michelle Magid, Tillmann H C Kruger, et al.
Journal of Psychiatric Practice|November 19, 2014
Emergency ECT in an incapacitated, medically compromised patient with Huntington's diseaseMichelle Magid, Kenneth Trevino, William H Reid, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|April 19, 2018
Isotretinoin: the ups are just as troubling as the downsJay M Truitt, Jason S Reichenberg, Kevin G Sharghi, et al.
Journal of Psychiatric Research|February 12, 2021
Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysisJara Schulze, Insa Neumann, Michelle Magid, et al.
Journal of the American Academy of Dermatology|December 26, 2015
Botulinum toxin for depression: Does patient appearance matter?Jason S Reichenberg, Aaron J Hauptman, Henry T Robertson, et al.
The Journal of Clinical Psychiatry|June 10, 2014
Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled studyMichelle Magid, Jason S Reichenberg, Poppy E Poth, et al.
Frontiers in Psychiatry|April 19, 2014
Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trialM Axel Wollmer, Nadeem Kalak, Stefanie Jung, et al.
Pageof 3